Supernus Pharmaceuticals reported $-444000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US USD 2.49B 486M
Aurora Cannabis Inc ACB:CN CAD -63864000 556.28M
Canopy Growth Corp WEED:CN CAD -223691000 1.86B
Cara Therapeutics CARA:US USD -23180000 18.97M
Eisai 4523:JP JPY -1588000000 11.31B
Horizon Pharma HZNP:US USD 315.1M 27.58M
Marinus Pharmaceuticals MRNS:US USD 75.04M 114.48M
Pfizer PFE:US USD 10.67B 3.11B
Revance Therapeutics RVNC:US USD -83993000 22.56M
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M
United Therapeutics UTHR:US USD 312.5M 161.9M